Search
Displaying all 3 results
Margetuximab
go.drugbank.com/drugs/DB14967
ApprovedInvestigational
The HER2 oncoprotein, the product of the human ERBB2/mouse neu genes, is a member of the HER family of receptor tyrosine kinases that includes the epidermal growth factor receptor (EGFR). Of the various subtypes of breast cancer, HER2-positive breast cancer is characterized by ERBB2 overexpression, a higher grade, a...
Metastatic Breast Cancer With HER2 Positive
go.drugbank.com/conditions/DBCOND0112973Tebotelimab
go.drugbank.com/drugs/DB16685InvestigationalTebotelimab is under investigation in clinical trial NCT04082364 (Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/gej Cancer (MAHOGANY)).